Clinical Trials Logo

Rectum Cancer clinical trials

View clinical trials related to Rectum Cancer.

Filter by:

NCT ID: NCT04443985 Completed - Rectum Cancer Clinical Trials

A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer

Start date: June 1, 2020
Phase:
Study type: Observational

Due to colorectal cancer is the fourth most common malignancy in the world. Some patients had present locally advance stage and need to preoperative concurrent chemoradiation (CCRT) before radical surgery. But predictor for pathologic complete response (pCR) after preoperative CCRT remain unclear. Objectives: To identify possible factor for predict of pCR of rectal cancer after preoperative CCRT.

NCT ID: NCT04405206 Recruiting - Rectum Cancer Clinical Trials

Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer

BJCC-R01
Start date: May 25, 2020
Phase:
Study type: Observational

Aim: To investigate the safety and efficacy of organ preservation (OP) with watch-and-wait strategy (W&W) or local excision (LE) in MRI stratified low-risk rectal cancer treated by total neoadjuvant treatment. Meanwhile we will look into the role of ctDNA in the prediction of regrowth and metastasis in the wait and wait process. Methods: Low-risk rectal cancer with following MRI features are recruited: mid-low tumor, mrT2-3b, MRF(-), EMVI(-), differentiation grade 1-3. Patients will receive IMRT 50.6Gy/22f with concurrent capecitabine and 4 cycles of consolidation CAPEOX. Patients with cCR/near-cCR were recommended for 'watch & wait' approach or local excision (LE). The OPR and sphincter preservation rate (SPR) at 2 years will be analyzed. As the extension of PKUCH-R01, BJCC-R01 trial will upgrade to a multi-center research enrolled 3 other colorectal center in Beijing.

NCT ID: NCT04371198 Completed - Rectum Cancer Clinical Trials

Patient-Derived Organoids for Rectal Cancer

Start date: September 18, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

NCT ID: NCT04109755 Recruiting - Rectal Cancer Clinical Trials

Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer

PEMREC
Start date: June 2, 2020
Phase: Phase 2
Study type: Interventional

This project investigates the clinical and biological impact of combining immunotherapy (pembrolizumab) with short course radiotherapy (5Gy, five times) in the neo-adjuvant treatment of localised microsatellite stable (MSS) rectal cancer.

NCT ID: NCT04015804 Active, not recruiting - Rectum Cancer Clinical Trials

Robotic Low Rectum Anterior Resection

GROG-R01
Start date: March 2015
Phase: N/A
Study type: Interventional

The laparoscopic approach for total mesorectal excision (L-TME) results improved short-term outcomes. However this approach has technical limitations when the pelvis is narrow and deep. Indeed there is a limited mobility of straight laparoscopic instruments and associated loss of dexterity, unstable camera view and compromised ergonomics for the surgeon. Robotic technology was developed to reduce these limitations and offers the advantages of intuitive manipulation of laparoscopic instruments with wrist articulation, a 3-dimensional field of view, a stable camera platform with zoom magnification, dexterity enhancement and an ergonomic operating environment. A major advantage of the robotic approach is the surgeon's simultaneous control of the camera and of the two or three additional instruments. This advantage facilitates traction and counter-traction. The technological advantages of robotic surgery should also allow a finer dissection in a narrow pelvic cavity.

NCT ID: NCT03843957 Completed - Cancer Clinical Trials

Effectiveness and Implementation of mPATH-CRC

Start date: October 31, 2019
Phase: N/A
Study type: Interventional

Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.

NCT ID: NCT03699761 Recruiting - Rectum Cancer Clinical Trials

The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

A randomized controlled clinical trial to compare the short and long outcomes of low anterior resection for middle-low rectal cancer with or without pelvic peritonization.

NCT ID: NCT03573791 Recruiting - Rectal Cancer Clinical Trials

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

Start date: May 21, 2018
Phase:
Study type: Observational

Neoadjuvant therapy has been widely applied to locally advanced rectal cancer. However, about 50% of patients receiving this therapy do not respond well as evidenced by the fact that their T or N stages are not effectively decreased judged by postoperative pathological examination. The purpose of this trail is to identify the biomarkers (from within patients' tumor mass before neoadjuvant therapy) to predict resistance to neoadjuvant therapy. These biomarkers can help stratify neoadjuvant-resistant patients towards surgery while avoiding unnecessary chemoradio-based neoadjuvant therapy.

NCT ID: NCT03445936 Active, not recruiting - Rectum Cancer Clinical Trials

PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure

Start date: February 13, 2018
Phase: N/A
Study type: Interventional

This study compares a synthetic mesh and biological implant in prevention of incisional hernia after loop-ileostomy closure.

NCT ID: NCT03345563 Active, not recruiting - Prostate Cancer Clinical Trials

Project HERO: Health Empowerment & Recovery Outcomes

HERO
Start date: July 19, 2019
Phase: N/A
Study type: Interventional

Project HERO is a 12-week study of the efficacy of Body Mind Training (BMT) for reducing fatigue in male cancer survivors. This 3-arm randomized clinical trial will examine inflammatory biology and selected gene-expression pathways that are hypothesized to contribute to the intervention's effect.